NL-OMON49288尚未招募不适用
Quality of life experience after neoadjuvant chemotherapy in HER2-positive breast cancer patients: a focus group study - Focus group TRAIN-2: quality of life.
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Signed informed consent
- •* * 18 years
- •* Treated in the TRAIN-2 study for stage II or III HER2-positive breast cancer
- •* Willing and being able to fill in a questionnaire
- •* Willing to speak about and discuss different domains of HRQoL
- •* Proficient in Dutch
排除标准
- •* Evidence of breast cancer recurrence / second primary cancer
- •* History of severe psychiatric illness or dementia
研究者
相似试验
已完成
不适用
Quality of Life During Neoadjuvant Chemotherapy of Breast CancerC50Malignant neoplasm of breastDRKS00016761Gesellschaft für Klinische Forschung e.V.54
Unknown
不适用
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant ChemotherapyQOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant ChemotherapyNCT04408859Peking University Cancer Hospital & Institute290
已完成
不适用
Effect of neoadjuvant chemotherapy in patients with gastric cancerIRCT2015020220906N1Vice chancellor for Research and Technology30
招募中
Unknown
The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patientsPancreatic cancerJPRN-UMIN000052925Juntendo University Hospital35
已完成
不适用
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48